Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
Author(s) -
Michael J. Schuh,
Sheena Crosby
Publication year - 2021
Publication title -
innovations in pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2155-0417
DOI - 10.24926/iip.v12i4.4034
Subject(s) - polypharmacy , pharmacogenomics , medicine , psychiatry , clinical pharmacy , medical diagnosis , neurology , patient care , family medicine , intensive care medicine , pharmacology , pharmacy , nursing , pathology
Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists.Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD.Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom